ZATA PHARMACEUTICALS

ZATA Pharmaceuticals is a privately held enterprise with origins in 2008 and is structured as a C-Corporation. A ZATA facility is located at Massachusetts Biomedical Initiatives (MBI) in Worcester, MA. Its unique technology makes ZATA Pharmaceuticals a great candidate for investment, collaboration, and partnerships. As potential therapeutics, they seek to synthesize and test chemically modified oligo-RNA and DNA derivatives that include leading expertise in nucleic acid derivatives as potential compounds. Furthermore, they have extensive expertise and exceptional IP in the development of blood safety products.